You searched for "blind"
How the other half live – ophthalmology training around the world
Ophthalmology speciality training is currently seven years in the UK without an additional fellowship. UK trainees are privileged to have a training programme that is held in high esteem across the world, but did you ever wonder what other trainees...Celebrations for 20 years of VCHP ring out from the city
20 years of Vision Care for Homeless People, and the 18,000+ people who have been helped to better vision through the regional drop-in clinics, were celebrated by a host of volunteers, charity founders and generous donors from the optical community last week.
Management of giant retinal tears with vitrectomy and perfluorocarbon liquid postoperatively as a short-term tamponade
The authors report an eight year retrospective case series study of 30 eyes of 29 patients with who underwent a giant retinal tear-related retinal detachment repair. M: F ratio was 23:6. Right to left eye ratio was 16:14. The mean...Cricket fan Tony credits NHS cataract surgery with improving his mental health as well as his sight
Tony, 65, could see the ball at Trent Bridge match ‘for the first time in years’ and says ‘everything’ in life has improved, after cataract removal at SpaMedica.90% of NHS trusts now have electronic patient records
The NHS has met the government’s target for 90% of trusts adopting electronic patient records (EPR) in hospitals ahead of schedule.
Post hoc analysis of the CANTREAT randomised trial
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...
Licence to save: a UK survey of anti-VEGF use for the eye
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...
Prediction errors of formulas in optical biometers
This study was conducted retrospectively in a private practice setting. Nine formulas were compared for prediction error (postoperative spherical equivalent (SE) minus, predicted SE calculated by each formula), using two optical biometers (Lenstar – optical low coherence reflectometry (OLCR) and...Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.OSA members call for a 5-year practice plan at 100% Optical
Making a five-year plan for an optical or ophthalmology business is uppermost in OSA members’ minds as they look for the best means of supporting the profession at 100% Optical.
